Virios Therapeutics Inc (VIRI)
0.2183
+0.01
(+5.36%)
USD |
NASDAQ |
May 31, 16:00
0.2174
0.00 (0.00%)
After-Hours: 20:00
Virios Therapeutics Total Liabilities (Quarterly): 0.5701M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.5701M |
| December 31, 2023 | 0.3585M |
| September 30, 2023 | 0.4871M |
| June 30, 2023 | 0.52M |
| March 31, 2023 | 0.5493M |
| December 31, 2022 | 1.043M |
| September 30, 2022 | 1.633M |
| June 30, 2022 | 1.898M |
| March 31, 2022 | 1.877M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.276M |
| September 30, 2021 | 1.227M |
| June 30, 2021 | 0.9063M |
| March 31, 2021 | 1.167M |
| December 31, 2020 | 1.532M |
| September 30, 2020 | 5.935M |
| June 30, 2020 | 7.336M |
| December 31, 2019 | 5.258M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3585M
Minimum
Dec 2023
7.336M
Maximum
Jun 2020
1.975M
Average
1.227M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 11.36M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.225M |
| Shareholders Equity (Quarterly) | 2.654M |